Christopher Posner - Nov 2, 2023 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role
President and CEO, Director
Signature
/s/Darren DeStefano, Attorney-in-Fact
Stock symbol
CARA
Transactions as of
Nov 2, 2023
Transactions value $
-$4,631
Form type
4
Date filed
11/3/2023, 04:37 PM
Previous filing
Aug 4, 2023
Next filing
Feb 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CARA Common Stock Sale -$4.63K -3.8K -2.26% $1.22 164K Nov 2, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person on November 2, 2022 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person.